Novozymes Statistics
Total Valuation
Novozymes has a market cap or net worth of DKK 217.44 billion. The enterprise value is 230.34 billion.
Market Cap | 217.44B |
Enterprise Value | 230.34B |
Important Dates
The last earnings date was Wednesday, August 28, 2024.
Earnings Date | Aug 28, 2024 |
Ex-Dividend Date | Aug 30, 2024 |
Share Statistics
Novozymes has 464.62 million shares outstanding. The number of shares has decreased by -0.26% in one year.
Shares Outstanding | 464.62M |
Shares Change (YoY) | -0.26% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 27.11% |
Float | 345.19M |
Valuation Ratios
The trailing PE ratio is 61.53 and the forward PE ratio is 35.27. Novozymes's PEG ratio is 3.81.
PE Ratio | 61.53 |
Forward PE | 35.27 |
PS Ratio | 5.70 |
PB Ratio | 1.58 |
P/FCF Ratio | 46.17 |
PEG Ratio | 3.81 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.51, with an EV/FCF ratio of 48.91.
EV / Earnings | 109.22 |
EV / Sales | 10.14 |
EV / EBITDA | 39.51 |
EV / EBIT | 59.22 |
EV / FCF | 48.91 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 18.08.
Current Ratio | 1.11 |
Quick Ratio | 0.67 |
Debt / Equity | 18.08 |
Debt / EBITDA | 2.53 |
Debt / FCF | 3.15 |
Interest Coverage | 11.54 |
Financial Efficiency
Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.
Return on Equity (ROE) | 4.38% |
Return on Assets (ROA) | 3.45% |
Return on Capital (ROIC) | 4.12% |
Revenue Per Employee | 2.17M |
Profits Per Employee | 201,775 |
Employee Count | 6,756 |
Asset Turnover | 0.32 |
Inventory Turnover | 2.66 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.95% in the last 52 weeks. The beta is 0.52, so Novozymes's price volatility has been lower than the market average.
Beta (5Y) | 0.52 |
52-Week Price Change | +55.95% |
50-Day Moving Average | 433.28 |
200-Day Moving Average | 397.00 |
Relative Strength Index (RSI) | 77.66 |
Average Volume (20 Days) | 549,190 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novozymes had revenue of DKK 22.71 billion and earned 2.11 billion in profits. Earnings per share was 7.61.
Revenue | 22.71B |
Gross Profit | 10.60B |
Operating Income | 3.92B |
Pretax Income | 2.74B |
Net Income | 2.11B |
EBITDA | 4.98B |
EBIT | 3.92B |
Earnings Per Share (EPS) | 7.61 |
Balance Sheet
The company has 1.94 billion in cash and 14.83 billion in debt, giving a net cash position of -12.89 billion or -27.74 per share.
Cash & Cash Equivalents | 1.94B |
Total Debt | 14.83B |
Net Cash | -12.89B |
Net Cash Per Share | -27.74 |
Equity (Book Value) | 82.07B |
Book Value Per Share | 295.29 |
Working Capital | 1.32B |
Cash Flow
In the last 12 months, operating cash flow was 6.64 billion and capital expenditures -1.93 billion, giving a free cash flow of 4.71 billion.
Operating Cash Flow | 6.64B |
Capital Expenditures | -1.93B |
Free Cash Flow | 4.71B |
FCF Per Share | 10.14 |
Margins
Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.
Gross Margin | 46.66% |
Operating Margin | 17.24% |
Pretax Margin | 12.07% |
Profit Margin | 9.29% |
EBITDA Margin | 21.92% |
EBIT Margin | 17.24% |
FCF Margin | 20.74% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.86%.
Dividend Per Share | 4.00 |
Dividend Yield | 0.86% |
Dividend Growth (YoY) | -60.78% |
Years of Dividend Growth | 2 |
Payout Ratio | 99.19% |
Buyback Yield | 0.26% |
Shareholder Yield | 1.11% |
Earnings Yield | 1.63% |
FCF Yield | 2.17% |
Stock Splits
The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.
Last Split Date | Nov 28, 2011 |
Split Type | Forward |
Split Ratio | 5 |